Suppression of EGFR autophosphorylation by FKBP12

Biochemistry

Volumn 50, Issue 50, 2011, Pages 10844-10850

  Mathea, Sebastian ^a   Li, Sen ^a,b   Schierhorn, Angelika ^a   Jahreis, Günther ^a   Schiene Fischer, Cordelia ^a  

^a MAX PLANCK RESEARCH UNIT FOR ENZYMOLOGY OF PROTEIN FOLDING   (Germany)

^b BEIJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHOSPHORYLATION; ENDOGENOUS INHIBITOR; FK506-BINDING PROTEINS; INTRACELLULAR SIGNALING; ISOMERASES; KINASE DOMAINS; PHOSPHORYLATION SITES;

CATALYST ACTIVITY; ENZYMES;

PHOSPHORYLATION;

EPIDERMAL GROWTH FACTOR RECEPTOR; FH506 BINDING PROTEIN 12; PEPTIDYLPROLYL ISOMERASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; CATALYSIS; CELLULAR DISTRIBUTION; ENZYME PHOSPHORYLATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ANTIBODIES, PHOSPHO-SPECIFIC; CARCINOMA; CELL LINE, TUMOR; CROSS-LINKING REAGENTS; DIMERIZATION; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; GENE SILENCING; HELA CELLS; HUMANS; KINETICS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TACROLIMUS BINDING PROTEIN 1A;

EID: 83455221764     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi2013855     Document Type: Article

References (32)

1. Schiene, C. and Fischer, G. (2000) Enzymes that catalyse the restructuring of proteins Curr. Opin. Struct. Biol. 10, 40-45 (Pubitemid 30099325)
2. Pratt, W. B. (1998) The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors Proc. Soc. Exp. Biol. Med. 217, 420-434
3. Kazlauskas, A., Poellinger, L., and Pongratz, I. (2002) Two distinct regions of the immunophilin-like protein XAP2 regulate dioxin receptor function and interaction with hsp90 J. Biol. Chem. 277, 11795-11801 (Pubitemid 34959963)
4. Ahern, G. P., Junankar, P. R., and Dulhunty, A. F. (1994) Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506 FEBS Lett. 352, 369-374 (Pubitemid 24302473)
5. Okadome, T., Oeda, E., Saitoh, M., Ichijo, H., Moses, H. L., Miyazono, K., and Kawabata, M. (1996) Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo J. Biol. Chem. 271, 21687-21690 (Pubitemid 26303779)
6. Schiene-Fischer, C. and Yu, C. (2001) Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases FEBS Lett. 495, 1-6 (Pubitemid 32367963)
7. Harding, M. W., Galat, A., Uehling, D. E., and Schreiber, S. L. (1989) A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase Nature 341, 758-760 (Pubitemid 19260893)
8. Siekierka, J. J., Hung, S. H., Poe, M., Lin, C. S., and Sigal, N. H. (1989) A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin Nature 341, 755-757 (Pubitemid 19260892)
9. Ahern, G. P., Junankar, P. R., and Dulhunty, A. F. (1997) Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12 Biophys. J. 72, 146-162 (Pubitemid 27043425)
10. Marks, A. R. (2002) Ryanodine receptors, FKBP12, and heart failure Front. Biosci. 7, 970-977
11. Chelu, M. G., Danila, C. I., Gilman, C. P., and Hamilton, S. L. (2004) Regulation of ryanodine receptors by FK506 binding proteins Trends Cardiovasc. Med. 14, 227-234 (Pubitemid 39297020)
12. Gellen, B. 2008, Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling Circulation 117, 1778-1786 (Pubitemid 351507466)
13. Wang, T. and Donahoe, P. K. (2004) The immunophilin FKBP12: a molecular guardian of the TGF-beta family type I receptors Front. Biosci. 9, 619-631 (Pubitemid 39043739)
14. Lopez-Ilasaca, M., Schiene, C., Küllertz, G., Tradler, T., Fischer, G., and Wetzker, R. (1998) Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor J. Biol. Chem. 273, 9430-9434 (Pubitemid 28183024)
15. Bublil, E. M. and Yarden, Y. (2007) The EGF receptor family: spearheading a merger of signaling and therapeutics Curr. Opin. Cell Biol. 19, 124-134 (Pubitemid 46386405)
16. Yarden, Y. and Schlessinger, J. (1987) Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor Biochemistry 26, 1443-1451 (Pubitemid 17045875)
17. Lammers, R., Van Obberghen, E., Ballotti, R., Schlessinger, J., and Ullrich, A. (1990) Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation J. Biol. Chem. 265, 16886-16890
18. Schlessinger, J. (2002) Ligand-induced, receptor-mediated dimerization and activation of EGF receptor Cell 110, 669-672 (Pubitemid 35283957)
19. Nicholson, R. I., Gee, J. M., and Harper, M. E. (2001) EGFR and cancer prognosis Eur. J. Cancer 37, 9-15
20. Zandi, R., Larsen, A. B., Andersen, P., Stockhausen, M. T., and Poulsen, H. S. (2007) Mechanisms for oncogenic activation of the epidermal growth factor receptor Cell. Signalling 19, 2013-2023 (Pubitemid 47353811)
21. ODonovan, N. and Crown, J. (2007) EGFR and HER-2 antagonists in breast cancer Anticancer Res. 27, 1285-1294 (Pubitemid 46813089)
22. Waterman, H., Katz, M., Rubin, C., Shtiegman, K., Lavi, S., Elson, A., Jovin, T., and Yarden, Y. (2002) A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling EMBO J. 21, 303-313 (Pubitemid 34137292)
23. Qian, X., Karpova, T., Sheppard, A. M., McNally, J., and Lowy, D. R. (2004) E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases EMBO J. 23, 1739-1748 (Pubitemid 38649637)
24. Shilo, B. Z. (2005) Regulating the dynamics of EGF receptor signaling in space and time Development 132, 4017-4027
25. Gur, G. 2004, LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation EMBO J. 23, 3270-3281 (Pubitemid 39209151)
26. Kario, E., Marmor, M. D., Adamsky, K., Citri, A., Amit, I., Amariglio, N., Rechavi, G., and Yarden, Y. (2005) Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling J. Biol. Chem. 280, 7038-7048 (Pubitemid 40341260)
27. Anastasi, S., Baietti, M. F., Frosi, Y., Alemà, S., and Segatto, O. (2007) The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity Oncogene 26, 7833-7846 (Pubitemid 350261785)
28. Tradler, T., Stoller, G., Rücknagel, K. P., Schierhorn, A., Rahfeld, J. U., and Fischer, G. (1997) Comparative mutational analysis of peptidyl prolyl cis/trans isomerases: active sites of Escherichia coli trigger factor and human FKBP12 FEBS Lett. 407, 184-190 (Pubitemid 27199489)
29. Yu, X., Sharma, K. D., Takahashi, T., Iwamoto, R., and Mekada, E. (2002) Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling Mol. Biol. Cell 13, 2547-2557 (Pubitemid 34831354)
30. Fan, Y. X., Wong, L., Deb, T. B., and Johnson, G. R. (2004) Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites J. Biol. Chem. 279, 38143-38150 (Pubitemid 39295960)
31. Landau, M. and Ben-Tal, N. (2008) Dynamic equilibrium between multiple active and inactive conformations explains regulation and oncogenic mutations in ErbB receptors Biochim. Biophys. Acta 1785, 12-31 (Pubitemid 350192080)
32. Gómez, A. M. 2009, Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins Circulation 119, 2179-2187